6 Problems around creating data visualisations
In this episode, I’ve gathered up six problems around creating data visualisations, so you can improve the quality of your visualisations.
Innovation
What you can expect in 2023 from me
And it’s almost time for another year and as the New Year brings a lot of challenges, I am excited to share with you my plans and projects for 2023 that you and I both will definitely benefit from.
First mover advantage and how it applies to statistics
In this conversation, we talk about the effective impact of the first-mover advantage. To give a more visual distinction of this strategy, it is more like a chess game where the first mover often decides the direction of the game.
Bonus Episode: Practical steps to improve your leadership skills
In this last part of the leadership series with Gary Sullivan, we talk about the next steps, you can take to work on your leadership skills.
Bonus Episode: Impactful influencing – actionable advice to get things done through and with others
In this episode, we have our first non-statistician as a guest. Julia has built her own consulting and training company Zestfor.
The Best Sources For RWE That You May Never Heard About
I first became aware of these sources for real-world evidence some years ago, and I tried to get an expert on this topic so often, but unfortunately, no one would speak with me. Then finally someone agreed when they found out what country my research was being conducted in-the Scandinavian Union! You might be wondering why we need data from such a unique place as Scandinavia? Stay tuned because you’ll find out soon enough… This region provides us statisticians everything we could hope: perfect measurements plus high-quality counts.
A Preview into the PSI Conference
This is a special episode while Benjamin and I talk about the upcoming PSI conference and what you can expect from it. This will be a face to face conference in Gothenburg, Sweden!
Patient-reported Outcomes and the FDA Patient-Focused Drug Development Guidance
In today’s episode, we discuss the process with the FDA publishing a timeline of planned public workshops, draft guidance documents and final guidance documents for 4 documents, originally planned to finish in end 2021 and its objective to explore the factors that need to be considered when developing COA-based endpoints.
Apps on Prescription Paid by the Government
In today’s episode, Dr. Stefan Walzer and I discussed the goal of the Digital Health Application.
What Does It Take to Develop Good Patient-Reported Outcomes?
In today’s episode, Antoine and I answer these questions and more. E.g. we talk about the importance of calibrating the relevance of the existing items in the questionnaire and developing new ones in order to reach more accurate measurements resulting in good PROs.
